DAI provides potential imaging biomarker to indicate brain tumor response to radiation therapy
- Posted: February 11, 2013
Diffusion abnormality index (DAI) shows promise as an imaging biomarker to measure brain tumor response to radiation therapy, according to University of Michigan research being presented at the 2013 Cancer Imaging and Radiation Therapy Symposium. The study included 20 patients who had brain metastases and were treated with whole brain radiotherapy. The University of Michigan is home to the University of Michigan Comprehensive Cancer Center.
Among the research institutions NCI funds across the United States, it currently designates 67 as Cancer Centers. Largely based in research universities, these facilities are home to many of the NCI-supported scientists who conduct a wide range of intense, laboratory research into cancer’s origins and development. The Cancer Centers Program also focuses on trans-disciplinary research, including population science and clinical research. The centers’ research results are often at the forefront of studies in the cancer field.